- BofA May Face $12 Billion Credit Cards Charge: KBW
- Bernanke: May Need to Tighten to Prevent Inflation
- Private Rescue of CIT Marks Shift in Crisis
- California Governor and Lawmakers Reach Budget Deal
- As Spain’s Economy Falters, Bank Robberies Rise
- Roubini: Recovery From Recession Will Be 'Very Ugly'
- Some China Universities Inflate Graduate Jobs Data
- Tuesday Look Ahead: Earnings May Trump Bernanke
- UK Financial Watchdog Issues Bonus Warning
- Jets Owner Says New Stadium Will Be Sold Out
- Toshiba Feeling the Blu's; Apple Next?
- Tech Stocks vs ETFs: Earnings Season Strategies
- CNBC’s Sports Twitter Rankings (July ’09)
- Toyota's New U.S. Boss: 'Time to Get Close to The Customer'
- Art Cashin: My Take on Goldman's S&P Call
- Lenny Dykstra, Michael Jackson, And Goldman Sachs is Running The Country - Your Emails
- Secular Bear Market For Another 10 Years: Strategist
- Lodging Losses Mount
- Ahead of the Bell: Apple to report 3Q results
- Finland's jobless rate at 9.1 pct in June
- Foot traffic at RI airport drops
- Ahead of the Bell: Starbucks to report 3Q results
- Debate starting on new French Internet piracy bill
- Report: Ho Ching to remain CEO of Temasek
- Continental Airlines posts 2Q loss
- UnitedHealth Group 2Q profit more than doubles
- Ryanair to trim aircraft by 40 pct at London hub
FDA warns of infections with transplant drugs
Text Size 
WASHINGTON - Federal health regulators said Tuesday they are adding new labeling about the risks of infection to organ transplant drugs made by Roche, Novartis and other drugmakers.
The Food and Drug Administration said it has received reports of dangerous viral infections in patients taking the drugs, which are typically used to avoid rejection following kidney transplant.
Drugs bearing the new labeling are: Roche's CellCept, Wyeth's Rapamune, Novartis' Myfortic, Sandimmune and Neoral.
The FDA said physicians should carefully monitor patients for signs of viral infection, which can sometimes lead to kidney failure.
The agency said it will continue to monitor reports of safety problems with the medications.
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Print
Email
Data is a real-time snapshot *Data is delayed at least 15 minutes